Fabrazyme and cardiac failure congestive Patient Reports February 11, 2012

Fabrazyme Side Effects Report #5792525-1
Fabrazyme side effect was reported by a Physician from JAPAN on June 10, 2008. Male patient, 83 years of age, weighting 119.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, c-reactive protein increased, cardiac failure congestive, cardiac hypertrophy, cholestasis, condition aggravated, disease recurrence. Fabrazyme dosage: 45 MG, Q2W, INTRAVENOUS. During the same period patient was treated with ASPIRIN, ACETAMINOPHEN, PIMOBENDAN, NICORANDIL, ALGINATE, FUROSEMIDE, OMEPRAZOLE, HYDROXYZINE PAMOATE. Patient was hospitalized. Patient died on 12/29/2004.

Fabrazyme Side Effects Report #4551347-X
Fabrazyme side effect was reported by a Physician from on Dec 26, 2004. Male patient, 83 years of age, weighting 101.4 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: base excess, blood urea increased, c-reactive protein increased, cardiac failure congestive, cardiomegaly, mitral valve incompetence, pneumonia , pulmonary congestion, renal function test abnormal. Fabrazyme dosage: 45 MG Q2WKS IV. During the same period patient was treated with ASPIRIN, ACETAMINOPHEN, ENALAPRIL MALEATE, PIMOBENDAN, NICORANDIL, ALGINATE, FUROSEMIDE, SPIRONOLACTONE. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #4556933-9
Fabrazyme side effect was reported by a Physician from on Jan 07, 2005. Male patient, 83 years of age, weighting 101.4 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: base excess negative, c-reactive protein increased, cardiac failure congestive, mitral valve incompetence, pco2 decreased, pneumonia , po2 decreased, renal failure, tricuspid valve incompetence. Fabrazyme dosage: 45 MG Q2WKS IV. During the same period patient was treated with ASPIRIN, ACETAMINOPHEN, ENALAPRIL MALEATE, PIMOBENDAN, NICORANDIL, ALGINATE, FUROSEMIDE, SPIRONOLACTONE. Patient was hospitalized. Patient died on 12/29/2004.

Fabrazyme Side Effects Report #4570551-8
Fabrazyme side effect was reported by a Physician from on Jan 19, 2005. Male patient, 83 years of age, weighting 119.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, base excess negative, blood lactate dehydrogenase increased, cardiac failure congestive, haematocrit decreased, haemoglobin decreased, mitral valve incompetence, multi-organ disorder. Fabrazyme dosage: 45 MG Q2WK IV. During the same period patient was treated with ASPIRIN, ACETAMINOPHEN, ENALAPRIL MALEATE, PIMOBENDAN, NICORANDIL, ALGINATE, FUROSEMIDE, SPIRONOLACTONE. Patient was hospitalized. Patient died on 12/29/2004.


Fabrazyme Side Effects Report #4578172-8
Fabrazyme side effect was reported by a Physician from on Feb 21, 2005. Male patient, 83 years of age, weighting 119.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, cardiac failure, cardiac failure congestive, cardiomegaly, haematocrit decreased, haemoglobin decreased. Fabrazyme dosage: 45 MG Q2WKS IV. During the same period patient was treated with ASPIRIN, ACETAMINOPHEN, ENALAPRIL, PIMOBENDAN, NICORANDIL, ALGINATE, FUROSEMIDE, SPIRONOLACTONE. Patient was hospitalized. Patient died on 12/29/2004.

Fabrazyme Side Effects Report #4652526-3
Fabrazyme side effect was reported by a Health Professional from on Apr 18, 2005. Male patient, 83 years of age, weighting 121.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure congestive, condition aggravated, myocardial fibrosis, myocarditis. Fabrazyme dosage: 55 MG Q2WKS IV. During the same period patient was treated with ZANTAC, GLICAZIDE, METFORMIN, AMIODARONE, METOPROLOL TARTRATE, MADOPAR. Patient died on 04/12/2005.

Fabrazyme Side Effects Report #4664798-X
Fabrazyme side effect was reported by a Consumer or non-health professional from on May 04, 2005. Male patient, 83 years of age, weighting 121.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure congestive, condition aggravated, myocarditis, renal impairment. Fabrazyme dosage: 55 MG Q2WKS IV. During the same period patient was treated with ZANTAC, GLICAZIDE, METFORMIN, AMIODARONE, METOPROLOL, MADOPAR. Patient died on 04/12/2005.

Fabrazyme Side Effects Report #5700827-X
Fabrazyme side effect was reported by a Physician from JAPAN on Mar 26, 2008. Male patient, 82 years of age, weighting 138.9 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure congestive, condition aggravated, disease progression. Fabrazyme dosage: 65 MG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5736364-6
Fabrazyme side effect was reported by a Physician from JAPAN on Apr 28, 2008. Male patient, 82 years of age, weighting 149.9 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure congestive, disease progression. Fabrazyme dosage: 65 MG, Q2W, INTRAVENOUS ; 65 MG, Q2W, INTRAVENOUS. During the same period patient was treated with ENALAPRIL MALEATE, FUROSEMIDE, SPIRONOLACTONE, CARBOCISTEINE, OXYGEN. Patient was hospitalized. Patient recovered.


Fabrazyme Side Effects Report #5326887-6
Fabrazyme side effect was reported by a Physician from JAPAN on May 01, 2007. Male patient, 80 years of age, weighting 147.7 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure congestive, condition aggravated. Fabrazyme dosage: 70 MG Q2WKS IV. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5736164-7
Fabrazyme side effect was reported by a Physician from JAPAN on Apr 28, 2008. Male patient, 80 years of age, weighting 149.9 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure congestive. Fabrazyme dosage: 60 MG, Q2W, INTRAVENOUS; 60 MG, Q2W, INTRAVENOUS. During the same period patient was treated with ENALAPRIL MALEATE, FUROSEMIDE, SPIRONOLACTONE, CARBOCISTEINE, OXYGEN. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5803585-3
Fabrazyme side effect was reported by a Physician from JAPAN on June 24, 2008. Male patient, 78 years of age, weighting 103.6 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: aortic valve incompetence, cardiac failure congestive, mitral valve incompetence, renal failure acute, tricuspid valve incompetence. Fabrazyme dosage: 45 MG, Q2W, INTRAVENOUS. During the same period patient was treated with ENALAPRIL MALEATE, FUROSEMIDE, ASPIRIN, CARVEDILOL, CERNITIN POLLEN, FAMOTIDINE, WARFARIN POTASSIUM, ALLOPURINOL. Patient was hospitalized. Patient died on 08/14/2005.

Fabrazyme Side Effects Report #4732959-7
Fabrazyme side effect was reported by a Physician from JAPAN on July 19, 2005. Male patient, 78 years of age, weighting 103.6 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure congestive. Fabrazyme dosage: 47 MG Q2WKS IV. During the same period patient was treated with ENALAPRIL, FUROSEMIDE, ASPIRIN, CARVEDILOL, CERNITIN POLLEN, FAMOTIDINE, ETIZOLAM, WARFARIN POTASSIUM. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #4754375-4
Fabrazyme side effect was reported by a Physician from JAPAN on Aug 16, 2005. Male patient, 78 years of age, weighting 103.6 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure congestive, condition aggravated, renal failure acute. Fabrazyme dosage: 47 MG Q2WKS IV. During the same period patient was treated with ENALAPRIL MALEATE, FUROSEMIDE, ASPIRIN, CARVEDILOL, CERNITIN POLLEN, FAMOTIDINE, ETIZOLAM, WARFARIN POTASSIUM. Patient was hospitalized. Patient died on 08/14/2005.


Fabrazyme Side Effects Report #4777568-9
Fabrazyme side effect was reported by a Physician from JAPAN on Sept 08, 2005. Male patient, 78 years of age, weighting 103.6 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure congestive, condition aggravated, renal failure acute. Fabrazyme dosage: 47 MG Q2WKS IV. During the same period patient was treated with ENALAPRIL MALEATE, FUROSEMIDE, ASPIRIN, CARVEDILOL, CERNITIN POLLEN, FAMOTIDINE, ETIZOLAM, WARFARIN POTASSIUM. Patient was hospitalized. Patient died on 08/14/2005.

Fabrazyme Side Effects Report #4906016-0
Fabrazyme side effect was reported by a Health Professional from UNITED STATES on Jan 25, 2006. Male patient, 65 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure congestive, cardiomyopathy , device related infection, staphylococcal infection . Fabrazyme dosage: 1 MG/KG IV. Patient was hospitalized. Patient died on 01/06/2006.

Fabrazyme Side Effects Report #5846131-0
Fabrazyme side effect was reported by a Physician from UNITED STATES on Aug 01, 2008. Male patient, 64 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure congestive, condition aggravated, supraventricular tachycardia. Fabrazyme dosage: 70 MG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5849874-8
Fabrazyme side effect was reported by a Physician from UNITED STATES on Aug 01, 2008. Male patient, 64 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure congestive, malaise, supraventricular tachycardia. Fabrazyme dosage: 70 MG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5876647-2
Fabrazyme side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 25, 2008. Male patient, 64 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: abdominal distension, cardiac failure congestive, left ventricular failure, tricuspid valve disease. Fabrazyme dosage: 1 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with AMIODARONE. Patient was hospitalized. Patient recovered.


Fabrazyme Side Effects Report #5911430-0
Fabrazyme side effect was reported by a Physician from UNITED STATES on Sept 22, 2008. Male patient, 64 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: abdominal distension, cardiac failure congestive, fluid retention, tricuspid valve incompetence, ventricular tachycardia. Fabrazyme dosage: 1 MG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5911905-4
Fabrazyme side effect was reported by a Physician from ITALY on Sept 23, 2008. Female patient, 63 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure congestive. Fabrazyme dosage: unknown. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5924697-X
Fabrazyme side effect was reported by a Physician from ITALY on Oct 02, 2008. Male patient, 63 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure congestive. Fabrazyme dosage: 70 MG, QOW, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5410317-X
Fabrazyme side effect was reported by a Consumer or non-health professional from UNITED STATES on July 25, 2007. Male patient, 62 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: asthma , cardiac failure congestive, cellulitis , chronic obstructive pulmonary disease, confusional state, deep vein thrombosis , fluid retention, hypokalaemia, implantable defibrillator malfunction. Fabrazyme dosage: 1 MG/KG Q2WKS IV. During the same period patient was treated with COUMADIN. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5443095-9
Fabrazyme side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 16, 2007. Male patient, 62 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure congestive. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with COUMADIN, LASIX, COREG, ZANTAC, LORTAB, KLONOPIN. Patient was hospitalized. Patient recovered.


Fabrazyme Side Effects Report #5452112-1
Fabrazyme side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 29, 2007. Male patient, 62 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: blood potassium decreased, cardiac failure congestive. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with COUMADIN, LASIX, COREG, ZANTAC, LORTAB, KLONOPIN. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5463817-0
Fabrazyme side effect was reported by a Physician from UNITED STATES on Sept 07, 2007. Male patient, 62 years of age, was diagnosed with fabry's disease, polyuria and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: blood creatine increased, blood potassium decreased, blood urea increased, cardiac failure congestive. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with LASIX, COUMADIN, COREG, ZANTAC, LORTAB, KLONOPIN. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5482025-0
Fabrazyme side effect was reported by a Physician from UNITED STATES on Sept 21, 2007. Male patient, 62 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: blood potassium decreased, cardiac failure congestive, device breakage, implantable defibrillator malfunction, pneumonia , ventricular tachycardia. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with LASIX, COUMADIN, COREG, ZANTAC, LORTAB. Patient was hospitalized. Patient died on 09/23/2007.

Fabrazyme Side Effects Report #5517734-8
Fabrazyme side effect was reported by a Health Professional from UNITED STATES on Nov 01, 2007. Male patient, 62 years of age, was diagnosed with fabry's disease, polyuria and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: atelectasis, blood potassium decreased, cardiac failure congestive, cardiomyopathy , disease progression, hypotension, implantable defibrillator malfunction, lethargy. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with LASIX, COUMADIN, COREG, ZANTAC, LORTAB. Patient was hospitalized. Patient died on 09/23/2007.

Fabrazyme Side Effects Report #4640211-3
Fabrazyme side effect was reported by a Physician from on Apr 05, 2005. Male patient, 57 years of age, weighting 135.1 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure congestive. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with COUMADIN, DILANTIN, RENAPLEX, ALLOPURINOL, PAXIL, VITAMIN D. Patient was hospitalized. Patient died on 04/04/2005.


Fabrazyme Side Effects Report #4884558-4
Fabrazyme side effect was reported by a Physician from UNITED STATES on Jan 06, 2006. Male patient, 57 years of age, weighting 179.7 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: aortic valve stenosis, atrial fibrillation , cardiac failure congestive, coronary artery disease , mitral valve incompetence, pulmonary hypertension , vascular bypass graft, ventricular hypertrophy. Fabrazyme dosage: 70 MG Q2WKS IV. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5408278-2
Fabrazyme side effect was reported by a Physician from SLOVENIA on July 24, 2007. Male patient, 56 years of age, weighting 119.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure acute, cardiac failure congestive, condition aggravated, mitral valve incompetence. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with ENALAPRIL MALEATE, ASPIRIN. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5907781-6
Fabrazyme side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 15, 2008. Male patient, 54 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure congestive, hernia . Fabrazyme dosage: 60 MG Q2W UNK. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5248710-0
Fabrazyme side effect was reported by a Health Professional from UNITED STATES on Feb 14, 2007. Male patient, 50 years of age, weighting 183.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure congestive, cardiomyopathy . Fabrazyme dosage: 85 MG Q2WKS IV. During the same period patient was treated with IBUPROFEN, TOPROL, COUMADIN, ASPIRIN, FOLIC ACID, VITAMIN B, BENADRYL. Patient recovered.

Fabrazyme Side Effects Report #5285480-4
Fabrazyme side effect was reported by a Physician from UNITED STATES on Mar 16, 2007. Male patient, 50 years of age, weighting 143.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure congestive, disease recurrence, fluid overload, heart transplant . Fabrazyme dosage: 1 MG/KG Q2WKS IV. During the same period patient was treated with SYNTHROID, AMIODARONE, ASPIRIN, LASIX, INSPRA, DIGOXIN, TOPROL. Patient was hospitalized. Patient recovered.


Fabrazyme Side Effects Report #4596911-7
Fabrazyme side effect was reported by a Physician from on Feb 14, 2005. Male patient, 50 years of age, weighting 218.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure congestive, dialysis , disease recurrence, fluid overload, muscle twitching, renal failure acute. Fabrazyme dosage: 105 MG Q2WKS IV. During the same period patient was treated with DIOVAN, BUMEX, COUMADIN. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #4967369-0
Fabrazyme side effect was reported by a Physician from UNITED STATES on Mar 24, 2006. Male patient, 50 years of age, weighting 143.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure congestive, fluid overload. Fabrazyme dosage: 65 MG Q2WKS IV. During the same period patient was treated with SYNTHROID, AMIODARONE, ASPIRIN, LASIX, INSPRA, DIGOXIN, TOPROL, ADVAIR DISKUS. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5031526-8
Fabrazyme side effect was reported by a Physician from UNITED STATES on June 02, 2006. Male patient, 50 years of age, weighting 218.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: atrial fibrillation , blood creatinine increased, bundle branch block right, cardiac failure congestive, creatinine renal clearance decreased, dialysis , disease recurrence, ejection fraction decreased, muscle twitching. Fabrazyme dosage: 105 MG Q2WKS IV. During the same period patient was treated with DIOVAN, BUMEX, COUMADIN. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5043178-1
Fabrazyme side effect was reported by a Physician from UNITED STATES on June 19, 2006. Male patient, 50 years of age, weighting 218.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: bundle branch block right, cardiac failure congestive, dialysis , disease recurrence, fluid overload, muscle twitching, renal failure acute, restrictive cardiomyopathy. Fabrazyme dosage: 105 MG Q2WKS IV. During the same period patient was treated with DIOVAN, BUMEX, COUMADEX. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #6071368-8
Fabrazyme side effect was reported by a Physician from UNITED STATES on Jan 28, 2009. Female patient, 46 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure congestive. Fabrazyme dosage: 80 MG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.


Fabrazyme Side Effects Report #5776026-2
Fabrazyme side effect was reported by a Health Professional from UNITED STATES on June 02, 2008. Male patient, 33 years of age, weighting 253.5 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure congestive, disease progression, dyspnoea, fabry's disease, haemodialysis, lymphoedema, pain , pulmonary oedema, renal impairment. Fabrazyme dosage: 105 MG, Q2W, INTRAVENOUS. During the same period patient was treated with ASPIRIN, DILANTIN, VALSARTAN, PHOSLO, FUROSEMIDE, CALCITRIOL. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5947785-0
Fabrazyme side effect was reported by a Consumer or non-health professional from COLOMBIA on Oct 27, 2008. Male patient, 18 years of age, weighting 81.57 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure congestive, pericardial haemorrhage. Fabrazyme dosage: 0.95 MG/KG, Q2W; INTRAVENOUS. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5989753-9
Fabrazyme side effect was reported by a Consumer or non-health professional from COLOMBIA on Nov 27, 2008. Male patient, 18 years of age, weighting 81.57 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure congestive, catheter site infection, headache , hypercholesterolaemia, hypertension, migraine , pain in extremity, pericardial effusion, peritonitis. Fabrazyme dosage: 0.95 MG/KG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #4886725-2
Fabrazyme side effect was reported by a Physician from JAPAN on Jan 13, 2006. Female patient, child 10 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure congestive. Fabrazyme dosage: 55 MG Q2WKS IV. Patient recovered.

Fabrazyme Side Effects Report #4867882-0
Fabrazyme side effect was reported by a Physician from JAPAN on Dec 14, 2005. Female patient was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure congestive. Fabrazyme dosage: 55 MG Q2WKS IV. Patient recovered.